English | 简体中文 | 繁體中文 | 한국어
Share:
Change in Valmet Oyj's holding of treasury shares

Valmet Oyj's stock exchange release on January 17, 2019 at 2:00 p.m. EET

On January 17, 2019 a total of 907 Valmet shares have been returned free of consideration to Valmet Oyj according to the terms and conditions of Long-term incentive plan 2015-2017. Originally, the shares were transferred to the participants after the 2017 performance period of the plan.

After the return Valmet Oyj holds a total of 247,706 own shares.

Further information, please contact:
Calle Loikkanen, Director, Investor Relations, Valmet, tel. +358 10 672 0020

VALMET

Kari Saarinen
CFO

Calle Loikkanen
Director, Investor Relations

Valmet is the leading global developer and supplier of process technologies, automation and services for the pulp, paper and energy industries. We aim to become the global champion in serving our customers.

Valmet's strong technology offering includes pulp mills, tissue, board and paper production lines, as well as power plants for bioenergy production. Our advanced services and automation solutions improve the reliability and performance of our customers' processes and enhance the effective utilization of raw materials and energy.

Valmet's net sales in 2017 were approximately EUR 3.1 billion. Our more than 12,000 professionals around the world work close to our customers and are committed to moving our customers' performance forward - every day. Valmet's head office is in Espoo, Finland and its shares are listed on the Nasdaq Helsinki.

Read more www.valmet.com, www.twitter.com/valmetglobal

Follow Valmet IR on Twitter www.twitter.com/valmetir

Processing of personal data




This announcement is distributed by West Corporation on behalf of West Corporation clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Valmet via Globenewswire

Copyright © Thomson Reuters 2019. All rights reserved.
Press Releases
Novartis provides update on Phase III PARAGON-HF trial in heart failure patients with preserved ejection fraction (HFpEF)  
July 29, 2019 07:00 ET
Novartis receives positive CHMP opinion for Lucentis® treatment in preterm infants with retinopathy of prematurity (ROP), a disease causing visual impairment and blindness  
July 26, 2019 14:06 ET
Eastman Announces Second-Quarter 2019 Financial Results  
July 26, 2019 05:29 ET
Eastman Announces Second-Quarter 2019 Financial Results  
July 25, 2019 23:05 ET
Strong clinical progress in H1 and transformative collaboration with Gilead announced  
July 25, 2019 22:02 ET
Verisk to Acquire PASCO's Aerial Survey Business in U.S. to Strengthen Data Acquisition Capacity under Geomni  
July 25, 2019 05:29 ET
Verisk to Acquire PASCO's Aerial Survey Business in U.S. to Strengthen Data Acquisition Capacity under Geomni  
July 24, 2019 23:01 ET
Eastman Schedules Second-Quarter 2019 Financial Results News Release and SEC Form 8-K Filing, Teleconference and Webcast  
July 8, 2019 22:59 ET
AIR Publishes Its Catastrophe Exposure Data Schema Publicly  
July 1, 2019 16:59 ET
AIR Worldwide Releases Expanded Inland Flood Model for Central Europe  
June 25, 2019 16:29 ET
More News >>
Copyright © 2019 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: